{"id":2097056,"external_id":"11290841","country_code":"PT","object":"Ajuste direto para aquisição de A53311- Acalabrutinib [100 mg; cáp/comp]","procedure_type":"Ajuste Direto Regime Geral","contract_type":"Aquisição de bens móveis","cpv_code":"33600000","base_price":1260138.0,"total_effective_price":42428.0,"publication_date":"2025-03-18","celebration_date":"2025-01-20","location":"Portugal, Porto, Porto","bidder_count":1,"contracting_entity":{"name":"Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.","tax_identifier":"506362299","country_code":"PT","is_public_body":true},"bidders":[{"raw_label":"502942240-ASTRAZENECA-PRODUTOS FARMACÊUTICOS,LDA.","name":"ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA","tax_identifier":"502942240","is_company":true}],"winners":[{"name":"ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA","tax_identifier":"502942240","is_company":true}],"flags":[{"flag_type":"A2_PUBLICATION_AFTER_CELEBRATION","severity":"high","score":40,"details":{"publication_date":"2025-03-18","celebration_date":"2025-01-20","gap_days":57,"rule":"A2/A3 late publication: 57 days after signing (threshold: 10)"},"fired_at":"2026-03-06T17:18:26Z"},{"flag_type":"A6_LOW_COMPETITION","severity":"medium","score":20,"details":{"rule":"a6_single_bidder","bidder_count":1},"fired_at":"2026-04-17T21:42:59Z"},{"flag_type":"A9_PRICE_REDUCTION","severity":"low","score":10,"details":{"base_price":"1260138.0","total_effective_price":"42428.0","ratio":"0.0337","direction":"reduction","rule":"A9 price reduction: ratio 0.0337 outside [0.5, 1.5]"},"fired_at":"2026-03-06T17:21:47Z"}],"risk_score":70,"data_source":{"name":"Portal BASE","source_type":"api","last_synced_at":"2026-04-17T21:31:32Z"},"exported_at":"2026-10-28T19:00:07Z"}